Sirona Dental Systems, Inc. Prices Public Secondary Offering

LONG ISLAND CITY, N.Y.--(Business Wire)--
Sirona (Nasdaq: SIRO) announced today the pricing of the public secondary
offering of 7,500,000 shares of its common stock by Sirona Holdings Luxco S.C.A.
at a price to the public of $23.75 per share. The selling stockholder has
granted the underwriters a 30-day option to purchase up to an additional
1,125,000 shares to cover over-allotments, if any.

The Company will not receive any of the proceeds from the sale of shares of
common stock by the selling stockholder in this offering, but will pay certain
expenses.

J.P. Morgan Securities Inc. and BofA Merrill Lynch are the joint book-running
managers for the offering. William Blair & Company, LLC is co-lead manager and
Jefferies & Company, Inc. and Credit Suisse Securities (USA) LLC are
co-managers.

The offering is being made under a shelf registration statement filed with the
Securities and Exchange Commission, and is expected to close on August 12, 2009.

This press release does not constitute an offer to sell or a solicitation of an
offer to buy the securities described herein, nor shall there be any sale of
these securities in any state or jurisdiction in which such an offer,
solicitation or sale would be unlawful prior to registration or qualification
under the securities law of any such jurisdiction. The offering is being made by
means of a prospectus and the related preliminary prospectus supplement only.
Copies of the prospectus and the related preliminary prospectus supplement can
be obtained from J.P. Morgan Securities Inc. at 4 Chase Metrotech Center, CS
Level, Brooklyn, New York 11245, Attn: Chase Distribution and Support Service,
Northeast Statement Processing, or by telephone at 718-242-8002 and BofA Merrill
Lynch, 4 World Financial Center, New York, NY 10080, Attn: Prospectus
Department.

About Sirona Dental Systems

Sirona is a leading global manufacturer of technologically advanced, high
quality dental equipment. Sirona develops, manufactures, and markets a complete
line of dental products, including the CAD/CAM restoration equipment (CEREC),
digital and film-based intra-oral, panoramic and cephalometric X-ray imaging
systems, dental treatment centers and handpieces. Contact John Sweeney, CFA,
Vice President, Investor Relations, at 718-482-2184 or john.sweeney@sirona.com
for more information about Sirona and its products.

This press release and any attachment thereto contains forward-looking
information about Sirona Dental Systems, Inc.'s financial results, guidance and
estimates, business prospects, and products and services that involve
substantial risks and uncertainties or other factors that may cause actual
results, performance or achievements to be materially different from any future
results, performance or achievements expressed or implied by such
forward-looking statements. You can identify these statements by the use of
words such as "may," "could," "estimate," "will," "believe," "anticipate,"
"think," "intend," "expect," "project," "plan," "target," "forecast", and
similar words and expressions which identify forward-looking statements within
the meaning of the Private Securities Litigation Reform Act of 1995. Such
statements are not guarantees of future performance and involve known and
unknown risks and uncertainties, and other factors. Readers are cautioned not to
place undue reliance on such statements, which speak only as of the date hereof.
For a discussion of such risks, uncertainties and other matters that could cause
actual results to differ materially, including risks relating to, among other
factors, the market for dental product and services, pricing, future sales
volume of the Company's products, the possibility of changing economic, market
and competitive conditions, dependence on products, dependence on key personnel,
technological developments, intense competition, market uncertainties,
dependence on distributors, ability to manage growth, dependence on key
suppliers, dependence on key members of management, government regulation,
acquisitions and affiliations, readers are urged to carefully review and
consider various disclosures made by the Company in its Annual Report on Form
10-K and in its reports on Forms 10-Q and 8-K filed with the U.S. Securities and
Exchange Commission. The Company assumes no obligation to update any
forward-looking statements contained in this document or the attachments to
reflect new information or future events or developments after the date any such
statement is made.

Sirona Dental Systems, Inc.
John Sweeney, CFA, 718-482-2184
Vice President, Investor Relations
john.sweeney@sirona.com

Copyright Business Wire 2009